These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 212276)
1. Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs. Vollmer RR; Boccagno JA; Harris DN; Murthy VS Eur J Pharmacol; 1978 Sep; 51(1):39-45. PubMed ID: 212276 [TBL] [Abstract][Full Text] [Related]
2. Influence of inhibition of angiotensin I converting enzyme with SQ-14225 on the arterial blood pressure of mongrel dogs. Jandhyala BS; Washington GF; Lokhandwala MF Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):257-65. PubMed ID: 216064 [TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of the hypotensive action of SQ-14225, an angiotensin-converting enzyme inhibitor in anesthetized dogs. Jandhyala BS; Nandiwada P; Buckley JP; Lokhandwala MF Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):429-46. PubMed ID: 228363 [TBL] [Abstract][Full Text] [Related]
4. Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs. Miura K; Abe Y; Yamamoto K J Pharmacol Exp Ther; 1982 Jul; 222(1):246-50. PubMed ID: 6177851 [TBL] [Abstract][Full Text] [Related]
5. Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs. Harris DN; Heran CL; Goldenberg HJ; High JP; Laffan RJ; Rubin B; Antonaccio MJ; Goldberg ME Eur J Pharmacol; 1978 Oct; 51(4):345-9. PubMed ID: 213295 [TBL] [Abstract][Full Text] [Related]
6. Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats. Hutchinson JS; Mendelsohn FA; Doyle AE Hypertension; 1980; 2(2):119-24. PubMed ID: 6991407 [TBL] [Abstract][Full Text] [Related]
7. Hypotensive effect of captopril, an angiotensin converting enzyme inhibitor in pentobarbital anesthetized dogs. Satoh S; Fujisawa S; Tanaka R; Nakai K Jpn J Pharmacol; 1980 Feb; 30(1):112-5. PubMed ID: 6249947 [No Abstract] [Full Text] [Related]
8. Influence of converting enzyme inhibition on the release of vasopressin induced by angiotensin. Knepel W; Meyer DK Br J Pharmacol; 1980; 71(1):337-41. PubMed ID: 6162497 [TBL] [Abstract][Full Text] [Related]
9. Relationship between plasma renin activity and hypotensive effect of captopril in dogs. Hamed AT; Lokhandwala MF; Buckley JP; Jandhyala BS Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):195-204. PubMed ID: 6994184 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiotensin-converting enzyme by SQ 14,225 in anesthetized dogs: hemodynamic and renal vascular effects. Murthy VS; Waldron TL; Goldberg ME Proc Soc Exp Biol Med; 1978 Jan; 157(1):121-4. PubMed ID: 202968 [No Abstract] [Full Text] [Related]
11. [Renin and aldosterone secretion under converting enzyme inhibition]. Nakamura K Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075 [TBL] [Abstract][Full Text] [Related]
12. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat. Marks ES; Bing RF; Thurston H; Swales JD Clin Sci (Lond); 1980 Jan; 58(1):1-6. PubMed ID: 6986224 [TBL] [Abstract][Full Text] [Related]
13. Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats. Vollmer RR; Boccagno JA Eur J Pharmacol; 1977 Sep; 45(2):117-25. PubMed ID: 198216 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of a phosphorus-containing novel angiotensin converting enzyme inhibitor, SQ 29 852 in anesthetized dogs. Ohara N; Yokota S; Konishi C; Shukunobe K; Ono H J Pharmacobiodyn; 1991 Dec; 14(12):655-62. PubMed ID: 1812274 [TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of captopril induced hypotension in rats. Clarke DE; Wagner LB; Wagner LA Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):13-30. PubMed ID: 7020011 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiotensin conversion and prevention of renal hypertension. Miller ED; Samuels AI; Haber E; Barger AC Am J Physiol; 1975 Feb; 228(2):448-53. PubMed ID: 235218 [TBL] [Abstract][Full Text] [Related]
17. Hypotensive effect of captopril in relation to plasma renin activity in anesthetized rats. Satoh S; Suzuki M; Satoh H J Pharmacobiodyn; 1980 May; 3(5):258-60. PubMed ID: 6997455 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs. Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882 [TBL] [Abstract][Full Text] [Related]
19. A specific orally active inhibitor of angiotensin-converting enzyme in man. Ferguson RK; Turini GA; Brunner HR; Gavras H; McKinstry DN Lancet; 1977 Apr; 1(8015):775-8. PubMed ID: 66571 [TBL] [Abstract][Full Text] [Related]
20. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats. Suzuki M; Satoh S Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]